Pneumococcal Meningitis Clinical Trial
Official title:
Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone
Adding vancomycin to the antibiotic regimen is recommended for the treatment of pneumococcal meningitis in adults. Use of dexamethasone as adjunct therapy has proved to reduce mortality and neurologic sequelae in adult patients with pneumococcal meningitis. However, use of dexamethasone may impair penetration of vancomycin in cerebrospinal fluid. In a purely observational manner, we thought to measure blood and CSF concentrations of vancomycin in adult patients with pneumococcal meningitis, treated with vancomycin, third-generation cephalosporin and dexamethasone.
Because of a considerable increase in streptococcus pneumoniae meningitis with penicillin
nonsusceptible strains, it is now largely recommended to add vancomycin to the
third-generation cephalosporin antibiotic regimen. It has also been recently shown that use
of dexamethasone reduces mortality and unfavorable outcome in adults with pneumococcal
meningitis. However, concern has arisen, that dexamethasone may impair penetration of
vancomycin in cerebrospinal fluid.
We therefore thought to measure in a purely observational study, blood and CSF vancomycin
concentrations in adult patients with pneumococcal meningitis hospitalized in medical
intensive care unit that received third-generation cephalosporin, vancomycin and
dexamethasone. The aim of the study was to observe whether or not sufficient concentrations
of vancomycin could be measured in the CSF despite the concomitant use of dexamethasone.
Patients were cared for in a perfectly routine manner. There was no randomization. All
patients received routine, recommended care (IDSA guidelines). There was no invasive
procedure. Dexamethasone was administered according to the de Gans study (NEJM 2002). In
these patients with severe meningitis, a second lumbar puncture was performed as
recommended(IDSA Guidelines, CID 2004). At the same time, peripheral blood was taken. In
both samples, vancomycin concentration was determined.
;
Observational Model: Defined Population, Time Perspective: Longitudinal
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01478035 -
Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
|
Phase 4 | |
| Recruiting |
NCT03480191 -
Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis
|
Phase 2 | |
| Completed |
NCT00227214 -
Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.
|
N/A |